One of the most frightening facts about statins is that in 75 percent of cases, they are prescribed to healthy individuals for preventative purposes, as a ‘primary prevention’ measure against heart disease. However, overwhelming research shows that using statins for primary prevention does nothing to increase life expectancy.
Studies show that the instances of heart attacks in statin patients were somewhat lower, but this was cancelled out by the other diseases that occurred in these patients while on statins, very likely caused by the statins themselves due to their inhibition of cellular function and their blockage of vital nutrients.
In the 25 percent of patients prescribed statins after a cardiac event, stroke, or surgical heart intervention, the statins did increase life expectancy slightly. However, when the statistics were compiled, the life expectancy of these patients rose by only 14 days.
Statins are one of the most widely-prescribed classes of drugs in the world, and provide the pharmaceutical industry with billions of dollars in profits each year. Dr. John Abramson of Harvard Medical School explains how the scientific evidence backing statin use is entirely influenced by commercial interests.
No comments:
Post a Comment